OTCMKTS:QTXB

QuantRx Biomedical (QTXB) Stock Price, News & Analysis

$0.0040
0.00 (0.00%)
(As of 04/23/2024 ET)
Today's Range
$0.0040
$0.0040
50-Day Range
N/A
52-Week Range
$0.0002
$0.01
Volume
N/A
Average Volume
N/A
Market Capitalization
$314,800.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About QuantRx Biomedical

QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its products include InSync, a feminine hygienic interlabial pad; Unique miniform, a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon.

QTXB Stock Price History

QTXB Stock News Headlines

Quantrx Biomedical Corp QTXB
Global Biomedical Tester Market Research Report 2022-2032
Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
QTXB.PK - | Stock Price & Latest News | Reuters
See More Headlines
Receive QTXB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for QuantRx Biomedical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
OTCMKTS:QTXB
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
61,462,000
Market Cap
$314,800.00
Optionable
Not Optionable
Beta
-2.13
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Dr. Shalom Z. Hirschman M.D. (Age 88)
    Chairman of the Board, CEO & Principal Accounting Officer

QTXB Stock Analysis - Frequently Asked Questions

How have QTXB shares performed in 2024?

QuantRx Biomedical's stock was trading at $0.0079 at the beginning of 2024. Since then, QTXB shares have decreased by 49.4% and is now trading at $0.0040.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of QuantRx Biomedical own?
How do I buy shares of QuantRx Biomedical?

Shares of QTXB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:QTXB) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners